ABSTRACT

Atypical chronic myeloid leukemia is rare myelodysplastic syndrome BCR- ABL negative. The major problem in treatment is no current standard of care. We present a case of patient with aCML treated with azacytydyne. After 7 cycles of chemotheraphy he achieved PR.

KEYWORDS: atypical chronic myeloid leukemia, rare myelodysplastic syndrome, case, azacytydyne.

Zdjęcie: autorki – archiwum prywatne, przypadków – dzięki uprzejmości prof. E. Tarasowa (4)

Piśmiennictwo

1. Gotlib J. How I treat atypical chronic myeloid leukemia in Blood 2017;129:838-45; doi:https://doi.org/10.1182/blood-2016-08-693630

2. Dao KH, Tyner JW. What’s different about atypical CML and chronic neutrophilic leukemia? Hematology Am Soc Hematol Educ Program. 2015;264-71

3. Wang SA, Hasserjian RP, Fox PS et al. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood. 2014;123(17):2645-51

4. Meggendorfer M, Haferlach T, Alpermann T et al. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia. Haematologica. 2014;99(12):e244-e246

5. Dao KH, Solti MB, Maxson JE et al. Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I – positive atypical chronic myeloid leukemia. Leuk Res Rep. 2014;3(2):67-9

6. Mao L, You L, Yang M et al. The first case of decitabine successfully in treatment of atypical chronic myeloid leukemia with CEPBPA double mutation. Chemotherapy. 2013;2:114

7. Tong X, Li J, Zhou Z, Zheng D, Liu J, Su C. Efficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia. Leuk Lymphoma. 2015;56(6):1911-13

8. Hausmann H, Bhatt VR, Yuan J, Maness LJ, Ganti AK. Activity of single-agent decitabine in atypical chronic myeloid leukemia. J Oncol Pharm Pract. 2016; 22 (6): 790-794.

9. Jiang H, Wu Z, Ren LI, Tao D, Tong H. Decitabine for the treatment of atypical chronic myeloid leukemia: a report of two cases. Oncol Lett. 2016;11(1):689-92

Do góry